J L Montastruc, O Rascol. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Antiparkinson Agents/administration & dosageAntiparkinson Agents/adverse effectsBenzhydryl Compounds/administration & dosageBenzhydryl Compounds/adverse effectsBenzothiazolesCentral Nervous System Stimulants/administration & dosageCentral Nervous System Stimulants/adverse effectsDisorders of Excessive Somnolence/chemically inducedDisorders of Excessive Somnolence/drug therapyDopamine Agonists/administration & dosageDopamine Agonists/adverse effectsHumansModafinilParkinsonian Disorders/drug therapyPramipexoleThiazoles/administration & dosageThiazoles/adverse effectsTreatment Outcome
Substances： See more » Antiparkinson AgentsBenzhydryl CompoundsBenzothiazolesCentral Nervous System StimulantsDopamine AgonistsThiazolesPramipexoleModafinil
Year: 2001 PMID： 11481716 DOI： 10.1002/mds.1146
Source DB: PubMed Journal: Mov Disord ISSN： 0885-3185 Impact factor: 10.338